▶ Full Post Text
**Listings:** FSE: **J4U** (Frankfurt) | TSX-V: **TELI** (Canada) **Sector:** Deep Tech / Chemical Engineering / Critical Minerals
I’ve been digging into **Telescope Innovations (TSX-V: TELI / FSE: J4U)** recently. I used AI to help synthesize various research notes, filings, and posts I’ve collected to put this summary together.
**The Elevator Pitch:** Rather than betting on a single binary event (like a biotech finding a miracle drug), Telescope is an infrastructure play. They aren't trying to invent the medicine; they are building the intelligent factory capable of discovering it. It’s a convergence of industrial chemistry, robotics, and AI.
Here is the breakdown of the tech, the lithium pivot, and the financials.
# 1. The Tech: The "Self-Driving Lab" (SDL)
The core concept here is the SDL. In a traditional lab, a scientist runs a manual experiment, logs results, sleeps, and iterates the next day. It’s slow.
**The Telescope SDL loop:**
1. **Robot** runs the experiment.
2. **AI** analyzes results in real-time.
3. **AI** autonomously decides the next step to optimize the outcome.
4. **Robot** executes the next step immediately.
**Validation:** They announced this system in November and delivered it three weeks later. While giants like Eli Lilly ($LLY) and Merck ($MRK) are building similar internal systems, their involvement validates the market need. Telescope’s goal is to provide this infrastructure to the rest of the market.
# 2. The Product: DirectInject™ (Solving the Bottleneck)
The biggest frustration in chem-labs is analytical latency (sampling, prepping, waiting). DirectInject injects samples directly from the reactor into analytical instruments (HPLC/GC).
**Why it’s different from standard tools:**
* **Automated Quenching:** It doesn't just move liquid; it automates extraction, dilution, and *quenching* (chemically stopping the reaction). This freezes the reaction state, preventing data from being skewed by degradation after sampling.
* **Slurry Handling:** Solids usually clog tubing. TELI uses an in-line dynamic mixer to homogenize solid-liquid slurries, allowing for real-time analysis of complex mixtures without clogging.
* **Biphasic Sampling:** It can selectively sample from different phases in liquid-liquid mixtures (organic vs. aqueous).
* **Real-Time Chromatography:** Unlike IR/Raman probes (which can be vague), this feeds directly into chromatographs for full impurity profiling in real-time.
# 3. The Pivot: ReCRFT & The Lithium Wildcard
This is where the potential upside sits. They have applied their crystallization tech to lithium recycling (the ReCRFT platform).
* **The Problem:** "Black mass" (recycled battery waste) yields dirty lithium. Purifying it usually takes \~10 chemical-heavy steps.
* **The Solution:** ReCRFT uses automated crystallization to turn battery waste (or impure brines) into battery-grade Lithium Carbonate (>99.9%) in just **1 or 2 steps**.
* **Funding:** This efficiency secured them **$3.6M CAD** in government funding.
**Macro Context (2026 Outlook):** Lithium is classified as a critical mineral by the EU, US, and Canada. While prices crashed in 2024, the 2026 outlook is tightening.
* **Demand:** Energy Storage Systems (ESS) demand is surging (+70% YoY).
* **Supply:** Mine closures in places like Yichun (China) are limiting supply.
* **Prices:** Chinese carbonate prices have rebounded (\~€12,300/t).
* Telescope is positioned to facilitate "zero waste" supply chains, partnering with companies like **Standard Lithium** and **Cellmine**.
# 4. Credibility & Partners
* **Scientific Board:** Includes **K. Barry Sharpless**, a **two-time Nobel Prize winner** (Chemistry). This is a massive stamp of approval for their tech stack.
* **Management:** CEO Jason Hein is a UBC Professor and well-known in automated chemistry.
* **Partners:** They aren't selling door-to-door. They have distribution/partnerships with **Mettler Toledo** (global scale), **Shimadzu**, and historic collaboration with **Pfizer**.
# 5. Financials: The Inflection Point
Looking at the Fiscal Year 2025 and recent quarters (Q2/Q3 2025), the company is transitioning from R&D to commercialization.
* **Revenue:** grew **30.5%** to \~$5.78M in 2025.
* *Breakdown:* \~$4.78M Sales/Services + \~$1M in non-dilutive Grants.
* **Burn Rate:** Adjusted EBITDA is approaching breakeven (Losses were roughly -$100k to -$400k in recent quarters).
* **Cash:** Stable around \~$1.0M thanks to revenue and grants.
* **Projections:** Targeting $7.8M revenue in 2026 and $15.1M by 2027 via the Mettler Toledo ramp-up.
**The Bull Case:** Unlike many deep-tech/biotech small caps that burn $5M a quarter with zero revenue, TELI is effectively self-funding. They are spending heavily on wages/consulting, but that is to support the scale-up.
# 6. Risks
* **Liquidity:** It is a micro-cap (TSX-V). Volume can be dry; entry/exit requires patience.
* **Adoption:** Moving industries to SDL (robotic automation) requires a paradigm shift.
* **Scale:** The tech works, but industrial scaling is always the hardest hurdle.
# Summary
Telescope looks like a rare "J-Curve" setup. The market seems to be sleeping on the combination of a revenue-generating chemical business and a high-upside Lithium recycling play, validated by a Nobel laureate and government funding.
**Disclosure:** I am long TELI. This is not financial advice. Do your own research.
**Sources:**
* [SDL Demo Video](https://www.youtube.com/watch?v=9m4F78sUdII)
* [Government Funding Announcement ($3.6M)](https://investingnews.com/telescope-innovations-conditionally-approved-for-up-to-3-36-m-in-government-funding-to-advance-lithium-processing-technology/)
* [Lithium Market Analysis (Benchmark Minerals)](https://www.google.com/search?q=https://www.benchmarkminerals.com/lithium-ess-demand-surge-2026/)
* [Google Search: Lithium Prices/Supply 2026](https://www.google.com/search?q=https://www.benchmarkminerals.com/lithium-ess-demand-surge-2026/)
* Financial Data: Telescope Innovations SEDAR Filings 2025 & Financial Reports.